Literature DB >> 19901020

Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.

Meng-Lei Zhu1, Natasha Kyprianou.   

Abstract

Androgens are functionally required for the normal growth of the prostate gland and in prostate tumor development and progression. Epithelial-mesenchymal-transition (EMT) is an important process during normal development and in cancer cell metastasis induced by factors within the microenvironment, such as transforming growth factor-beta (TGF-beta). This study examined the ability of androgens to influence EMT of prostate cancer epithelial cells. The EMT pattern was evaluated on the basis of expression of the epithelial markers E-cadherin/beta-catenin, and the mesenchymal markers N-cadherin, as well as cytoskeleton reorganization in response to 5alpha-dihydrotestosterone (DHT; 1 nM) and/or TGF-beta (5 ng/ml). Overexpressing and silencing approaches to regulate androgen receptor (AR) expression were conducted to determine the involvement of AR in EMT in the presence or absence of an AR antagonist. Our results demonstrate that androgens induce the EMT pattern in prostate tumor epithelial cell with Snail activation and lead to significant changes in prostate cancer cell migration and invasion potential. Expression levels of AR inversely correlated with androgen-mediated EMT in prostate tumor epithelial cells, pointing to a low AR content required for the EMT phenotype. These findings indicate the ability of androgens to induce EMT by potentially bypassing the functional involvement of TGF-beta, thus contributing to metastatic behavior of prostate cancer cells.-Zhum, M.-L., Kyprianou, N. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901020      PMCID: PMC2830130          DOI: 10.1096/fj.09-136994

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  50 in total

Review 1.  Epithelial-mesenchymal transitions in development and pathologies.

Authors:  Jean Paul Thiery
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 2.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 3.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

Authors:  Stefan Grünert; Martin Jechlinger; Hartmut Beug
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

Review 4.  Convergence of Wnt, beta-catenin, and cadherin pathways.

Authors:  W James Nelson; Roel Nusse
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

5.  Testosterone formation and metabolism during male sexual differentiation in the human embryo.

Authors:  P K Siiteri; J D Wilson
Journal:  J Clin Endocrinol Metab       Date:  1974-01       Impact factor: 5.958

6.  The prognostic significance of epithelial-mesenchymal transition in breast cancer.

Authors:  Ilka B Fuchs; Werner Lichtenegger; Helmut Buehler; Wolfgang Henrich; Harald Stein; Anke Kleine-Tebbe; Gerhard Schaller
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

7.  Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.

Authors:  Hong-Yo Kang; Ko-En Huang; Shiuh Young Chang; Wen-Lung Ma; Wen-Jye Lin; Chawnshang Chang
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

8.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

9.  Cofilin promotes actin polymerization and defines the direction of cell motility.

Authors:  Mousumi Ghosh; Xiaoyan Song; Ghassan Mouneimne; Mazen Sidani; David S Lawrence; John S Condeelis
Journal:  Science       Date:  2004-04-30       Impact factor: 47.728

10.  The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase.

Authors:  J Imperato-McGinley; Z Binienda; A Arthur; D T Mininberg; E D Vaughan; F W Quimby
Journal:  Endocrinology       Date:  1985-02       Impact factor: 4.736

View more
  98 in total

1.  Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells.

Authors:  Xinhai Wan; Jie Liu; Jing-Fang Lu; Vassiliki Tzelepi; Jun Yang; Michael W Starbuck; Lixia Diao; Jing Wang; Eleni Efstathiou; Elba S Vazquez; Patricia Troncoso; Sankar N Maity; Nora M Navone
Journal:  Clin Cancer Res       Date:  2012-02-01       Impact factor: 12.531

2.  A transcriptional repressor co-regulatory network governing androgen response in prostate cancers.

Authors:  Kern Rei Chng; Cheng Wei Chang; Si Kee Tan; Chong Yang; Shu Zhen Hong; Noel Yan Wei Sng; Edwin Cheung
Journal:  EMBO J       Date:  2012-04-24       Impact factor: 11.598

Review 3.  Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer.

Authors:  Christopher J Logothetis; Gary E Gallick; Sankar N Maity; Jeri Kim; Ana Aparicio; Eleni Efstathiou; Sue-Hwa Lin
Journal:  Cancer Discov       Date:  2013-06-28       Impact factor: 39.397

4.  Gene expression signatures of site-specificity in cancer metastases.

Authors:  Franz Hartung; Aditya Patil; Rohan J Meshram; Georg F Weber
Journal:  Clin Exp Metastasis       Date:  2019-09-25       Impact factor: 5.150

5.  ASK-ing EMT not to spread cancer.

Authors:  Natasha Kyprianou
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-09       Impact factor: 11.205

6.  N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy.

Authors:  Sarah K Martin; Carmen A Banuelos; Marianne D Sadar; Natasha Kyprianou
Journal:  Mol Oncol       Date:  2014-11-15       Impact factor: 6.603

7.  Relationship between LSD1 expression and E-cadherin expression in prostate cancer.

Authors:  Min Wang; Xiuheng Liu; Guanjun Jiang; Hui Chen; Jia Guo; Xiaodong Weng
Journal:  Int Urol Nephrol       Date:  2015-01-28       Impact factor: 2.370

8.  The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.

Authors:  Jung-Jin Park; Mee-Hee Park; Eun Hye Oh; Nak-Kyun Soung; Soo Jae Lee; Jae-Kyung Jung; Ok-Jun Lee; Seok Joong Yun; Wun-Jae Kim; Eun-Young Shin; Eung-Gook Kim
Journal:  Oncogene       Date:  2018-05-30       Impact factor: 9.867

9.  Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.

Authors:  Juliane Colditz; Benjamin Rupf; Caroline Maiwald; Aria Baniahmad
Journal:  Mol Cell Biochem       Date:  2016-08-25       Impact factor: 3.396

Review 10.  The role of Snail in prostate cancer.

Authors:  Bethany N Smith; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.